期刊文献+

冠心病患者的CD_(41)水平及介入治疗对其影响

The CD_(41) levels in patients with coronary heart disease and the influence of PCI on CD_(41) levels
下载PDF
导出
摘要 目的研究冠心病患者的CD41水平,以及冠脉内介入治疗(PCI)术对CD41水平的影响。方法测定所有患者(包括258例冠心病患者及98例非冠心病患者)的CD41水平。行PCI术者(235例)及仅行冠状动脉造影(CAG)的患者(121例)术前及术后2h的CD41水平。结果冠心病者的CD41水平明显高于非冠心病者。CD41水平在PCI术后2h显著高于术前(P<0.05),而在仅行CAG术的患者CD41水平无明显变化(P>0.05)。结论冠心病患者的血小板活性高于非冠心病者,PCI术可促进血小板激活。 Objective To observe CD41 levels in patients with coronary heart disease and to investigate the influence of percutaneous coronary artery interventional therapy (PCI) on CD41 levels. Methods The CD41 levels in 258 patients with coronary heart disease ( CHD group) and 98 patients with non-coronary heart disease (NCHD group) were detected,and the CD41 levels in 235 patients who received PCI and 121 patients who received coronary angiogram(CAG) were detected by flow cytometry before and 2 hours after operation. Results The CD41 levels in CHD group were significantly higher than those in NCHD group. The CD4L levels at 2 hours after PCI were significantly higher than those before operation( P 〈0. 05 ), however, there was no significant difference in CD41 levels in the patients who received simple CAG before and after PCI ( P 〉 0.05). Conclusion The activity of platelet in patients with CHD is higher than that in patients with NCHD, and PCI can promote platelet activation.
出处 《河北医药》 CAS 2012年第19期2890-2891,共2页 Hebei Medical Journal
基金 广东省卫生厅科技项目(编号:B2003123)
关键词 冠心病 经皮冠状动脉介入治疗 CD41 coronary heart disease percutaneous coronary artery interventional therapy CD41
  • 相关文献

参考文献6

  • 1Gabbasov ZA, Agapov AA, Saburova OS, et al. Circulating stromal osteonectin-positive progenitor cells and stenotic coronary atherosclero- sis. Can J Physiol Pharmacol,2007 ,85 :295-300.
  • 2李文杰,吴沃栋,卢雄.急性心肌梗死患者外周血CD41/CD61与C反应蛋白的相关性及对预后的价值[J].临床心血管病杂志,2006,22(7):417-419. 被引量:3
  • 3Qi x, Peng Y, Gu J, Li S, et at. Inflammatory cytokine release in patients with unstable angina after coronary angioplasty. Jpn Heart J, 2002,43 : 103-115.
  • 4李俊勇,孙智敏,齐晓勇,王燕舞.冠心病患者介入治疗前后血小板CD41、CD62p的表达[J].白求恩军医学院学报,2006,4(4):195-196. 被引量:3
  • 5Gurbel PA, Bliden KP. Platelet activation after stenting with heparin-coa- ted versus noncoated stents. Am Heart J ,2003,146 : E10.
  • 6Gawaz M, Ruf A, Neumann FJ, et al. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement. Thromb Haemost, 1998,80:994-1001.

二级参考文献15

  • 1田乃亮,陈绍良,马玉玲,刘志忠,段宝祥.血清E-选择素和血清C-反应蛋白在急性冠状动脉综合征患者中的变化及意义[J].临床心血管病杂志,2005,21(6):328-329. 被引量:4
  • 2李俊勇,齐晓勇,李英肖,孙智敏.冠心病患者支架术后再狭窄的多因素回归分析[J].中国综合临床,2005,21(12):1070-1072. 被引量:15
  • 3[3]Ray MJ,Walters DL,Bett JN,et al.Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by Abciximab.Int J Cardiol,2005,101 (2):249-255.
  • 4[4]Mitsios JV,Papathanasiou AI,Elisaf M,et al.The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.Platelets,2005,16 (5):287-92.
  • 5[5]Lev EI,Patel RT,Maresh KJ,et al.Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention:the role of dual drug resistance.J Am Coll Cardiol,2006,47(1):27-33.
  • 6MONDORO T H, WALL C D, WHITE M M, et al.Selective induction of a glycoprotein Ⅲ a ligand-indueed binding site by fibrinogen and yon Willebrand factor[J]. Blood, 1996,88:3824-3830.
  • 7MCCOLLAM P L, FOSTER D A, RIESMEYER J S,et al. Cost and effectiveness of glycoprotein Ⅱ b/Ⅲ a-receptor inhibitors in patients with acute myocardial infarction undergoing percutaneous coronary intervention[J]. Am J Health Syst Pharm, 2003,60: 1251-1256.
  • 8CHENG D K, JACKEVICIUS C A, SEIDELIN P, et al. Safety of glycoprotein Ⅱ b/Ⅲ a inhibitors in urgent or emergency coronary artery bypass graft surgery[J]. Can J Cardiol, 2004,20:223-228.
  • 9DU CLOS T W, MARNELL L,ZLOCK L R, et al.Analysis of the binding of c-reactive protein to chromatin subunits[J]. J Immunol, 1991, 146: 1220-1225.
  • 10ANZAI T, YOSHIKAWA T, SHIRAKI H, et al. Creactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction[J]. Circulation, 1997, 96: 778- 784.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部